Recall notice
Xanax XR, Alprazolam recalled due to Failed Dissolution Specifications, United States
vor 5 Tagen •source accessdata.fda.gov
United States
Viatris, Inc. has initiated a recall of Xanax XR (alprazolam) extended-release tablets, 3 mg, due to failed dissolution specifications. The product was distributed nationwide across the United States.AFFECTED PRODUCT:
PRODUCT: Xanax XR, alprazolam
- In 60-tablet bottles
- With lot number 8177156
- An expiration date of February 28, 2027.
- It is identified by NDC 58151-506-91.
- The tablets were made in Ireland and distributed by Viatris Specialty LLC.
The recall, classified as Class II, was voluntarily initiated by the firm on March 17, 2026. The classification was confirmed on April 8, 2026, and the recall is currently ongoing.
Source: www.accessdata.fda.gov/scripts/ires/index.cfm
Bemerkungen
Kommentar